Media Summary: Clinical Pharmacologist Dr. Colin Pillai discusses if there are differences between an industry versus a regulatory setting, or if ... Dr. Jeff Barrett from the Critical path Institute describes the application of Rajesh Krishna, Senior Director with IDD Certara, reflects on how
Midd Training Module 3 Impact And Decision Making - Detailed Analysis & Overview
Clinical Pharmacologist Dr. Colin Pillai discusses if there are differences between an industry versus a regulatory setting, or if ... Dr. Jeff Barrett from the Critical path Institute describes the application of Rajesh Krishna, Senior Director with IDD Certara, reflects on how This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ... This lecture by Jeffrey Barrett from the Critical Path Institute describes the Jeffrey Barrett from the Critical Path Institute provides the overview of this
Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ... Dr. Mark R. Gasronguay, Founder and CEO of the Metrum Research Group, asks “why use models?” when there's observed data, ... Dr. Mark R. Gasronguay, Founder and CEO of the Metrum Research Group, discusses how to use simulation from a mathematical ...
